table of content
1 Study Coverage
1.1 Urology Drugs Product Introduction
1.2 Global Urology Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Urology Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Urology Drugs Sales in Volume for the Year 2017-2028
1.3 United States Urology Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Urology Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Urology Drugs Sales in Volume for the Year 2017-2028
1.4 Urology Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Urology Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Urology Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Urology Drugs Market Dynamics
1.5.1 Urology Drugs Industry Trends
1.5.2 Urology Drugs Market Drivers
1.5.3 Urology Drugs Market Challenges
1.5.4 Urology Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Urology Drugs Market Segment by Type
2.1.1 ? (alpha) Blockers
2.1.2 5 ?-reductase Inhibitors
2.2 Global Urology Drugs Market Size by Type
2.2.1 Global Urology Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Urology Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Urology Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Urology Drugs Market Size by Type
2.3.1 United States Urology Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Urology Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Urology Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Urology Drugs Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Urology Drugs Market Size by Application
3.2.1 Global Urology Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Urology Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Urology Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Urology Drugs Market Size by Application
3.3.1 United States Urology Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Urology Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Urology Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Urology Drugs Competitor Landscape by Company
4.1 Global Urology Drugs Market Size by Company
4.1.1 Top Global Urology Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Urology Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Urology Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Urology Drugs Price by Manufacturer (2017-2022)
4.2 Global Urology Drugs Concentration Ratio (CR)
4.2.1 Urology Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Urology Drugs in 2021
4.2.3 Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Urology Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Urology Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Urology Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Urology Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Urology Drugs Market Size by Company
4.5.1 Top Urology Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Urology Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Urology Drugs Sales by Players (2020, 2021 & 2022)
5 Global Urology Drugs Market Size by Region
5.1 Global Urology Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Urology Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Urology Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Urology Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Urology Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Urology Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Urology Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Urology Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Urology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Urology Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Urology Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Urology Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Urology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Urology Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Urology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Urology Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Urology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Astellas
7.1.1 Astellas Corporation Information
7.1.2 Astellas Description and Business Overview
7.1.3 Astellas Urology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Astellas Urology Drugs Products Offered
7.1.5 Astellas Recent Development
7.2 Endo
7.2.1 Endo Corporation Information
7.2.2 Endo Description and Business Overview
7.2.3 Endo Urology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Endo Urology Drugs Products Offered
7.2.5 Endo Recent Development
7.3 GP Pharm
7.3.1 GP Pharm Corporation Information
7.3.2 GP Pharm Description and Business Overview
7.3.3 GP Pharm Urology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 GP Pharm Urology Drugs Products Offered
7.3.5 GP Pharm Recent Development
7.4 Tolmar
7.4.1 Tolmar Corporation Information
7.4.2 Tolmar Description and Business Overview
7.4.3 Tolmar Urology Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Tolmar Urology Drugs Products Offered
7.4.5 Tolmar Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Urology Drugs Industry Chain Analysis
8.2 Urology Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Urology Drugs Distributors
8.3 Urology Drugs Production Mode & Process
8.4 Urology Drugs Sales and Marketing
8.4.1 Urology Drugs Sales Channels
8.4.2 Urology Drugs Distributors
8.5 Urology Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
